Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
6.90T | 6.76T | 6.57T | 6.22T | 11.92T | 3.83T |
Gross Profit | |||||
3.63T | 3.54T | 3.33T | 3.27T | 9.17T | 1.24T |
EBIT | |||||
831.07B | 560.01B | 380.08B | 713.85B | 6.89T | -918.51B |
EBITDA | |||||
853.41B | 1.47T | 1.27T | 365.37B | 7.73T | 2.61T |
Net Income Common Stockholders | |||||
71.06B | -227.65B | -1.01T | -1.74T | 4.99T | -1.16T |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.78T | 6.19T | 7.11T | 5.36T | 4.78T | 3.61T |
Total Assets | |||||
44.98T | 46.72T | 43.94T | 47.54T | 45.75T | 37.26T |
Total Debt | |||||
20.93T | 21.36T | 20.73T | 22.82T | 20.04T | 14.77T |
Net Debt | |||||
14.77T | 15.18T | 13.80T | 17.65T | 15.38T | 11.40T |
Total Liabilities | |||||
33.27T | 33.49T | 33.70T | 36.33T | 34.29T | 30.38T |
Stockholders Equity | |||||
9.77T | 10.97T | 8.62T | 9.48T | 9.72T | 5.42T |
Cash Flow | Free Cash Flow | ||||
28.71B | -372.06B | 35.71B | -323.63B | -123.89B | -145.74B |
Operating Cash Flow | |||||
659.87B | 250.55B | 669.48B | 511.44B | 523.00B | 1.09T |
Investing Cash Flow | |||||
-1.72T | -841.46B | 228.18B | -3.06T | -16.86B | -4.37T |
Financing Cash Flow | |||||
-894.89B | -606.22B | 191.52B | 602.22B | 2.24T | 2.92T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $283.28B | 25.67 | 17.93% | 1.23% | 3.62% | 38.24% | |
79 Outperform | $30.42B | 25.97 | 9.58% | 2.92% | 0.03% | -2.27% | |
76 Outperform | $191.23B | 17.86 | 10.54% | 4.17% | -0.08% | -24.48% | |
73 Outperform | $181.14B | 10.38 | 18.27% | 6.24% | 0.61% | 50.39% | |
67 Neutral | $43.45B | 28.07 | 7.78% | 3.59% | 3.15% | -63.12% | |
58 Neutral | $25.21B | 3.07 | -13.86% | 4.29% | 2.47% | -43.03% | |
48 Neutral | $66.26B | 10.65 | 8.02% | 0.46% | -2.23% | ― |